Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing modified immune system cells programmed to sense and respond to cancer cells… https://t.co/tLNPRr7ZOA
    about 11 hours ago
  • New post on Science and Enterprise: T-Cells Engineered to Release Anti-Cancer Proteins https://t.co/cnj0oCw5rv #Science #Business
    about 11 hours ago
  • An engineering team designed a process for adding and protecting tiny particles of nutrients in foods, boosting the… https://t.co/BodRPSI5g3
    about 13 hours ago
  • New post on Science and Enterprise: Polymer-Coated Microparticles Boost Food Nutrition https://t.co/rdGMQxPk5V #Science #Business
    about 13 hours ago
  • New contributed post on Science and Enterprise: https://t.co/ErXv6FGPSF How To Avoid Lapses In Productivity
    about 19 hours ago

Please share Science & Enterprise

Computer Model Devised to Predict Drug Side Effects

Pills on table

(e-Magine Art/Flickr)

2 November 2015. A systems biology lab developed a prototype computer model that can test for potential side effects of drugs from an individual’s blood sample. The team led by bioengineering professor Bernhard Palsson at University of California in San Diego published its proof-of-concept results last week in the journal Cell Systems.

Palsson and first author Aarash Bordbar are founders of the San Diego start-up enterprise Sinopia Biosciences, developing a computational platform for modeling of biological processes involving blood cells. The journal paper reports as well that Palsson and co-author Neema Jamshidi hold a patent on large-scale data-driven kinetic modeling as applied to individuals.

The team from Palsson’s systems biology lab at UC-San Diego are seeking better ways of predicting a person’s reactions to drugs, which can be highly personalized as a result of genetic and metabolic factors. A tool for predicting reactions to drugs can help personalize the choice of medications, avoid adverse effects for individuals, and better identify candidates for clinical drug trials.

Because of the complexity of predicting a drug’s side effects, the UC-San Diego team needed to devise a kinetic model that addresses the dynamics of multiple interacting variables. The researchers constructed the model combining data from whole-genome sequencing and metabolism of red blood cells that determines the ability of blood to exchange oxygen and carbon dioxide to and from the lungs and tissues in the body. The team chose red blood cells for the prototype, because of their relative simplicity and availability in blood samples, as well as the rich platform offered by the cells to find indicators of drug side effects.

The researchers drew blood samples of about 8 milliliters (0.27 fluid ounces) from 24 volunteers, then built individualized predictive models based on their genomic profiles and red blood cell metabolism. The individual kinetic models use Mass Action Stoichiometric Simulation, a kinetic modeling approach developed by Palsson and Jamshidi, based on network models. They then tested the models with a simulated dose of the anti-viral hepatitis C drug ribavirin, which in 8 to 10 percent of cases induces anemia, or decrease in the number of red blood cells.

“A goal of our predictive model is to pinpoint specific regions in the red blood cell that might increase susceptibility to this side effect,” says Brodbar in a university statement, “and predict what will potentially happen to any particular patient on this drug over time.” With their model, tests of the simulated ribavirin dose identified 2 of the 24 volunteers with a predisposition to developing anemia from the drug.

For next steps, the UC-San Diego team plans to expand the number of individuals providing blood samples to hundreds as well as develop predictive models to cover more complex platelet cells. They eventually want to design a liver cell model, since a majority of drugs are metabolized in the liver, which also is where most side effects originate.

Read more:

*     *     *

Please share Science & Enterprise ...
error

Comments are closed.